Skip to main navigation Skip to search Skip to main content

SBIR Phase II: A mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women

Project: Research

Abstract & Details

Description

Award ID: 2233106

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is a novel, surgically implanted device for treating female stress urinary incontinence (SUI). Nearly 50% of women in the U.S. will suffer from stress urinary incontinence with age resulting in over 40 million suffering women by 2050. No pharmacological solutions currently exist and mesh-based midurethral slings (MUS) are the mainstay surgical option, even though they are associated with various long-term complications, challenges, and risks. Furthermore, all SUI repair products on the market are polypropylene mesh-based with no alternatives available. This project aims to address this gap in options with a mesh-free, sling-free, outpatient transvaginal repair device for female urinary incontinence. This Small Business Innovation Research (SBIR) Phase II project aims to develop and validate a novel, transvaginal surgical procedural technology for treating stress urinary incontinence. This project progresses findings from the SBIR Phase I project which demonstrated functional proof-of-concept biomechanical feasibility. This Phase II project aims to further the surgical procedure and system in a manner suitable for human use. The scope of technical activities includes design optimization, mechanical testing and validation, surgical procedure validation, biocompatibility testing, and histological characterization in a series of benchtop, cadaveric, and animal studies. The scope of the activities will be conducted in accordance with practices needed to demonstrate chronic implanted safety and efficacy in pre-clinical models in order to gain eventual U.S. regulatory approval. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

NSF Program Director: Edward Chinchoy
StatusActive
Effective start/end date01/01/2401/31/27

Funding

  • SBIR Phase II: $975,713.00

Active Fiscal Year

  • FY2024
  • FY2026
  • FY2025
  • FY2027

Start Fiscal Year

  • FY2024

TIP Programs

  • SBIR Phase II

Small Business

  • Yes

Key Technology Areas

  • Biotechnology
  • (confidence score: 99%)

Technology Foci

  • Medical Technology
  • (confidence score: 100%)

Congressional District at Award

  • District n. 09 of Illinois

Current Congressional District

  • District n. 09 of Illinois

United States

  • Illinois

Core Based Statistical Area (CBSA)

  • Chicago-Naperville-Elgin, IL-IN

County

  • County: Cook, IL

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint. Learn more about Elsevier's Fingerprint Engine here: https://beta.elsevier.com/products/elsevier-fingerprint-engine